Lung fibroblasts from patients with idiopathic pulmonary fibrosis exhibit genome-wide differences in DNA methylation compared to fibroblasts from nonfibrotic lung

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Huang, Steven K ^a   Scruggs, Anne M ^a   McEachin, Richard C ^a   White, Eric S ^a   Peters Golden, Marc ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POTASSIUM CHANNEL;

ADULT; AGED; ARTICLE; CARD10 GENE; CDKN2B GENE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; EXTRACELLULAR MATRIX; FEMALE; FIBROSING ALVEOLITIS; GENE EXPRESSION; GENOME; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LUNG FIBROBLAST; MALE; MGMT GENE; MORPHOGENESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ADOLESCENT; CASE CONTROL STUDY; CELL LINE; COMPARATIVE STUDY; DEMOGRAPHY; FIBROBLAST; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENE SILENCING; GENETICS; HUMAN GENOME; LUNG; METABOLISM; MIDDLE AGED; MOLECULAR GENETICS; PATHOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CELL LINE; CELL PROLIFERATION; CPG ISLANDS; DEMOGRAPHY; DNA METHYLATION; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; GENE SILENCING; GENOME, HUMAN; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; LUNG; MALE; MIDDLE AGED; MOLECULAR SEQUENCE ANNOTATION; YOUNG ADULT;

EID: 84925156003     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0107055     Document Type: Article

References (50)

1. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, et al. (2011) An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183: 788-824.
2. Bjoraker JA, Ryu JH, Edwin MK, Myers JL, Tazelaar HD, et al. (1998) Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 157: 199-203.
3. Buhling F, Wille A, Rocken C, Wiesner O, Baier A, et al. (2005) Altered expression of membrane-bound and soluble CD95/Fas contributes to the resistance of fibrotic lung fibroblasts to FasL induced apoptosis. Respir Res 6: 37.
4. Huang SK, Wettlaufer SH, Hogaboam CM, Flaherty KR, Martinez FJ, et al. (2008) Variable prostaglandin E2 resistance in fibroblasts from patients with usual interstitial pneumonia. Am J Respir Crit Care Med 177: 66-74.
5. Jordana M, Schulman J, McSharry C, Irving LB, Newhouse MT, et al. (1988) Heterogeneous proliferative characteristics of human adult lung fibroblast lines and clonally derived fibroblasts from control and fibrotic tissue. Am Rev Respir Dis 137: 579-584.
6. Raghu G, Chen YY, Rusch V, Rabinovitch PS (1988) Differential proliferation of fibroblasts cultured from normal and fibrotic human lungs. Am Rev Respir Dis 138: 703-708.
7. Sanders YY, Kumbla P, Hagood JS (2007) Enhanced myofibroblastic differentiation and survival in Thy-1(-) lung fibroblasts. Am J Respir Cell Mol Biol 36: 226-235.
8. Ajayi IO, Sisson TH, Higgins PD, Booth AJ, Sagana RL, et al. (2013) X-linked inhibitor of apoptosis regulates lung fibroblast resistance to Fas-mediated apoptosis. Am J Respir Cell Mol Biol 49: 86-95.
9. Huang SK, White ES, Wettlaufer SH, Grifka H, Hogaboam CM, et al. (2009) Prostaglandin E(2) induces fibroblast apoptosis by modulating multiple survival pathways. FASEB J 23: 4317-4326.
10. Maher TM, Evans IC, Bottoms SE, Mercer PF, Thorley AJ, et al. (2010) Diminished prostaglandin E2 contributes to the apoptosis paradox in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 182: 73-82.
11. Emblom-Callahan MC, Chhina MK, Shlobin OA, Ahmad S, Reese ES, et al. (2010) Genomic phenotype of non-cultured pulmonary fibroblasts in idiopathic pulmonary fibrosis. Genomics 96: 134-145.
12. Sisson TH, Maher TM, Ajayi IO, King JE, Higgins PD, et al. (2012) Increased survivin expression contributes to apoptosis-resistance in IPF fibroblasts. Adv Biosci Biotechnol 3: 657-664.
13. Trujillo G, Meneghin A, Flaherty KR, Sholl LM, Myers JL, et al. (2010) TLR9 differentiates rapidly from slowly progressing forms of idiopathic pulmonary fibrosis. Sci Transl Med 2: 57-82.
14. Wilborn J, Crofford LJ, Burdick MD, Kunkel SL, Strieter RM, et al. (1995) Cultured lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis have a diminished capacity to synthesize prostaglandin E2 and to express cyclooxygenase-2. J Clin Invest 95: 1861-1868.
15. Rabinovich EI, Kapetanaki MG, Steinfeld I, Gibson KF, Pandit KV, et al. (2012) Global methylation patterns in idiopathic pulmonary fibrosis. PLoS One 7: e33770.
16. Sanders YY, Ambalavanan N, Halloran B, Zhang X, Liu H, et al. (2012) Altered DNA methylation profile in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 186: 525-535.
17. Cisneros J, Hagood J, Checa M, Ortiz-Quintero B, Negreros M, et al. (2012) Hypermethylation-mediated silencing of p14ARF in fibroblasts from idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 303: L295-303.
18. Huang SK, Fisher AS, Scruggs AM, White ES, Hogaboam CM, et al. (2010) Hypermethylation of PTGER2 confers prostaglandin E2 resistance in fibrotic fibroblasts from humans and mice. Am J Pathol 177: 2245-2255.
19. Sanders YY, Pardo A, Selman M, Nuovo GJ, Tollefsbol TO, et al. (2008) Thy-1 promoter hypermethylation: a novel epigenetic pathogenic mechanism in pulmonary fibrosis. Am J Respir Cell Mol Biol 39: 610-618.
20. Hogaboam CM, Carpenter KJ, Evanoff H, Kunkel SL (2005) Approaches to evaluation of fibrogenic pathways in surgical lung biopsy specimens. Methods Mol Med 117: 209-221.
21. Braakhuis BJ, Tabor MP, Kummer JA, Leemans CR, Brakenhoff RH (2003) A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res 63: 1727-1730.
22. Slaughter DP, Southwick HW, Smejkal W (1953) Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 6: 963-968.
23. Huang S, Wettlaufer SH, Hogaboam C, Aronoff DM, Peters-Golden M (2007) Prostaglandin E(2) inhibits collagen expression and proliferation in patient-derived normal lung fibroblasts via E prostanoid 2 receptor and cAMP signaling. Am J Physiol Lung Cell Mol Physiol 292: L405-413.
24. Du P, Zhang X, Huang CC, Jafari N, Kibbe WA, et al. (2010) Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis. BMC Bioinformatics 11: 587.
25. Consortium M, Shi L, Reid LH, Jones WD, Shippy R, et al. (2006) The MicroArray Quality Control (MAQC) project shows inter-and intraplatform reproducibility of gene expression measurements. Nat Biotechnol 24: 1151-1161.
26. Guo L, Lobenhofer EK, Wang C, Shippy R, Harris SC, et al. (2006) Rat toxicogenomic study reveals analytical consistency across microarray platforms. Nat Biotechnol 24: 1162-1169.
27. Shi L, Jones WD, Jensen RV, Harris SC, Perkins RG, et al. (2008) The balance of reproducibility, sensitivity, and specificity of lists of differentially expressed genes in microarray studies. BMC Bioinformatics 9 Suppl 9: S10.
28. Huang SK, Scruggs AM, Donaghy J, McEachin RC, Fisher AS, et al. (2012) Prostaglandin E2 increases fibroblast gene-specific and global DNA methylation via increased DNA methyltransferase expression. FASEB J 26: 3703-3714.
29. Maunakea AK, Nagarajan RP, Bilenky M, Ballinger TJ, D'Souza C, et al. (2010) Conserved role of intragenic DNA methylation in regulating alternative promoters. Nature 466: 253-257.
30. Quelle DE, Ashmun RA, Hannon GJ, Rehberger PA, Trono D, et al. (1995) Cloning and characterization of murine p16INK4a and p15INK4b genes. Oncogene 11: 635-645.
31. Lindahl GE, Stock CJ, Shi-Wen X, Leoni P, Sestini P, et al. (2013) Microarray profiling reveals suppressed interferon stimulated gene program in fibroblasts from scleroderma-associated interstitial lung disease. Respir Res 14: 80.
32. Sartor MA, Mahavisno V, Keshamouni VG, Cavalcoli J, Wright Z, et al. (2010) ConceptGen: a gene set enrichment and gene set relation mapping tool. Bioinformatics 26: 456-463.
33. Choi MR, In YH, Park J, Park T, Jung KH, et al. (2012) Genome-scale DNA methylation pattern profiling of human bone marrow mesenchymal stem cells in long-term culture. Exp Mol Med 44: 503-512.
34. Redaelli S, Bentivegna A, Foudah D, Miloso M, Redondo J, et al. (2012) From cytogenomic to epigenomic profiles: monitoring the biologic behavior of in vitro cultured human bone marrow mesenchymal stem cells. Stem Cell Res Ther 3: 47.
35. Selman M, King TE, Pardo A (2001) Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 134: 136-151.
36. Grabiner BC, Blonska M, Lin PC, You Y, Wang D, et al. (2007) CARMA3 deficiency abrogates G protein-coupled receptor-induced NF-{kappa}B activation. Genes Dev 21: 984-996.
37. McAllister-Lucas LM, Ruland J, Siu K, Jin X, Gu S, et al. (2007) CARMA3/Bcl10/MALT1-dependent NF-kappaB activation mediates angiotensin II-responsive inflammatory signaling in nonimmune cells. Proc Natl Acad Sci U S A 104: 139-144.
38. Grombacher T, Eichhorn U, Kaina B (1998) p53 is involved in regulation of the DNA repair gene O6-methylguanine-DNA methyltransferase (MGMT) by DNA damaging agents. Oncogene 17: 845-851.
39. Bonner JC, Lindroos PM, Rice AB, Moomaw CR, Morgan DL (1998) Induction of PDGF receptor-alpha in rat myofibroblasts during pulmonary fibrogenesis in vivo. Am J Physiol 274: L72-80.
40. Meuten T, Hickey A, Franklin K, Grossi B, Tobias J, et al. (2012) WNT7B in fibroblastic foci of idiopathic pulmonary fibrosis. Respir Res 13: 62.
41. Selman M, Lin HM, Montano M, Jenkins AL, Estrada A, et al. (2003) Surfactant protein A and B genetic variants predispose to idiopathic pulmonary fibrosis. Hum Genet 113: 542-550.
42. Pozharskaya V, Torres-Gonzalez E, Rojas M, Gal A, Amin M, et al. (2009) Twist: a regulator of epithelial-mesenchymal transition in lung fibrosis. PLoS One 4: e7559.
43. Mene P, Pirozzi N (2010) Potassium channels: the 'master switch' of renal fibrosis? Nephrol Dial Transplant 25: 353-355.
44. Fraga MF, Ballestar E, Paz MF, Ropero S, Setien F, et al. (2005) Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci U S A 102: 10604-10609.
45. Han MK, Swigris J, Liu L, Bartholmai B, Murray S, et al. (2010) Gender influences Health-Related Quality of Life in IPF. Respir Med 104: 724-730.
46. Olson AL, Swigris JJ, Lezotte DC, Norris JM, Wilson CG, et al. (2007) Mortality from pulmonary fibrosis increased in the United States from 1992 to 2003. Am J Respir Crit Care Med 176: 277-284.
47. Kaz AM, Wong CJ, Dzieciatkowski S, Luo Y, Schoen RE, et al. (2014) Patterns of DNA methylation in the normal colon vary by anatomical location, gender, and age. Epigenetics 9: 492-502.
48. Lovinsky-Desir S, Ridder R, Torrone D, Maher C, Narula S, et al. (2014) DNA methylation of the allergy regulatory gene interferon gamma varies by age, sex, and tissue type in asthmatics. Clin Epigenetics 6: 9.
49. Martinez FJ, Safrin S, Weycker D, Starko KM, Bradford WZ, et al. (2005) The clinical course of patients with idiopathic pulmonary fibrosis. Ann Intern Med 142: 963-967.
50. Katzenstein AL, Mukhopadhyay S, Myers JL (2008) Diagnosis of usual interstitial pneumonia and distinction from other fibrosing interstitial lung diseases. Hum Pathol 39: 1275-1294.